-
Chinese medicine stocks that won two consecutive boards, and the stock price rose rapidly on November 14
Time of Update: 2022-12-04
For the reasons for the change in the stock, the analysis believes that it is mainly affected by three factors, including traditional Chinese medicine, industrial hemp, high-end generic drugs and other conceptual factors.
-
Good news! Shandong Dingxin was elected as a director unit of the Professional Committee of Chinese Herbal Medicine Processing Equipment
Time of Update: 2022-09-30
As a professional manufacturer in the field of shredding equipment, Shandong Dingxin has always focused on the innovation and breakthrough of shredding technology, continuously improving the crushing efficiency and crushing capacity of pulverizer equipment, and providing strong equipment and technical support for traditional Chinese medicine and other industries.
-
Nat Med: Offspring of people with inflammatory colitis are predisposed to autism
Time of Update: 2022-09-20
Genetic association between autism susceptibility and IBD, UC, and Crohn's disease (rg)A multi-gene risk score analysis of longitudinal studies of parents and children showed an association between maternal genetic susceptibility to IBD and autistic traits in children.
-
What kind of growing environment is needed for intelligent agricultural machinery to help peanuts sow high-quality peanuts
Time of Update: 2022-09-10
What kind of environment do peanuts need to grow?Li Songjian, deputy director of the Agricultural Technology Promotion Center of Shandong Qingdao Agricultural and Rural Bureau, said that China is the world's largest producer and consumer of peanuts.
-
What to do if EGFR targeted drugs are resistant? Combination therapies are worth trying
Time of Update: 2022-09-09
Through the domestic PD-1 inhibitors sindilizumab, bevacizumab biosimilars, pemetrexed and cisplatin, it can also bring better benefits to lung cancer patients who are targeted drug-resistant.
Through the domestic PD-1 inhibitors sindilizumab, bevacizumab biosimilars, pemetrexed and cisplatin, it can also bring better benefits to lung cancer patients who are targeted drug-resistant.
-
Proprietary Chinese medicine ushered in a wave of price cuts, and the transformation and upgrading of pharmaceutical companies is imperative
Time of Update: 2022-08-19
Recently, under the active promotion of the Municipal Medical Security Bureau, the results of the first batch of Chinese patent medicine inter-provincial alliance centralized procurement have also been implemented in Suining City .
-
One article to understand the competitive landscape of the domestic biosimilar drug market
Time of Update: 2022-08-11
1 Domestic biosimilars Ushering in a competitive landscape of blooming flowers At present, there are six biosimilars listed by domestic pharmaceutical companies: bevacizumab, adalimumab, trastuzumab, rituximab, denosumab and infliximab (see Table 1) .
-
2019 Annual Meeting of the American Academy of Neurology: Teva will announce the long-term efficacy and safety data of Fremanezumab
Time of Update: 2021-12-03
prevention Fremanezumab is a fully humanized monoclonal antibody directed against calcitonin gene-related peptide ( CGRP ) α and β .
Fremanezumab is a fully humanized monoclonal antibody directed against calcitonin gene-related peptide ( CGRP ) α and β .
-
Under the multiple pressures of centralized procurement and foreign investment, where is the way out for local pharmaceutical companies
Time of Update: 2021-10-01
On the one hand, under the background of normalization of centralized procurement, drug price reduction has become a trend, the industry is facing innovation and transformation, a group of small and medium-sized enterprises will face the situation of elimination, and the overall market competition will become more fierce; on the other hand, since China joined ICH in 2017, Mutual recognition of data has enabled local pharmaceutical companies to enjoy ICH dividends.
-
How to use human albumin in liver cirrhosis with ascites
Time of Update: 2021-05-21
The results showed that for patients with liver cirrhosis with grade 2 ascites, infusion of human albumin combined with diuretics and diuretics alone Compared with liquid resuscitation agents, it can significantly improve the effective rate of treatment (RR=3.
-
Counterfeit new crown vaccine sales with physiological saline! More than 80 people were arrested
Time of Update: 2021-02-11
In accordance with the unified deployment of the Ministry of Public Security, Jiangsu, Beijing, Shandong and other places of public security organs recently successfully cracked a case of large-size production and sale of fake new crown vaccine, beat the false nest, cut off the criminal chain, arrested more than 80 suspects, the scene seized more than 3000 fake new crown vaccine.
-
Organic Nutrition: Is It Really Important
Time of Update: 2021-02-04
Research published yesterday by FoodNavigator shows that when it comes to nutritional value and the risk of bacterial contamination, there is no difference between organic products and products produced by traditional farming methods.
-
53 pharmaceutical companies received government subsidies of up to 700 million yuan
Time of Update: 2021-01-31
01, Baiyunshan 702.7 million Yuan Baiyunshan received a total of 702.7 million yuan in government subsidies in January-December 2020, more than 1 million yuan including major new drug creation, patent
-
STM: New biomarkers help predict rejection after stem cell transplantation
Time of Update: 2020-10-13
9, 2020 /---MUSC Hollings Cancer Center researcher Dr. Sophie Paczesny and others recently published a new class of immunocellular biomarkers that may reveal which patients are most at risk of transplant anti-host disease (GVHD).
-
Immunotherapy short board, to help China's esophageal cancer diagnosis and treatment to climb a new peak
Time of Update: 2020-10-05
Esophageal cancer, as a high-risk and high-death cancer, has made very limited progress in treatment over the past decade, and it was not until recent years that immunotherapy was approved for second-
